| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2024 | Mar 29, 2024 | Outlook Therapeutics, Inc. | Director | Buy | 91.3 | +1,881 | 59.42% | ✗ | $22.2K |
| Oct 6, 2022 | Oct 11, 2022 | Outlook Therapeutics, Inc. | Director | Buy | 91.3 | +33,343 | 111.14% | ✗ | $42.9K |
| Dec 2, 2021 | Dec 2, 2021 | Outlook Therapeutics, Inc. | Director | Buy | 91.3 | +10,000 | 50.00% | ✗ | $13.9K |
| Apr 19, 2021 | Apr 20, 2021 | Outlook Therapeutics, Inc. | Director | Buy | 91.3 | +10,000 | 100.00% | ✗ | $18.2K |
| Sep 22, 2020 | Sep 22, 2020 | Outlook Therapeutics, Inc. | Director | Buy | 90.0 | +10,000 | 100.00% | ✗ | $7.2K |